Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05106296
Title Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Theodore S. Johnson
Indications

medulloblastoma

brain ependymoma

neuroectodermal tumor

glioblastoma

Therapies

Cyclophosphamide + Etoposide + Ibrutinib + Indoximod

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.